Blood thinning drug 'effectively lowers stroke risk'

Posted on 06 April 2011

A revolutionary blood thinning drug could come to the aid of more than one million people, many of whom will be paying for long term care, if it is approved by European regulators.

Dabigatran etexilate, known as Pradaxa, has been found to significantly reduce the risk of stroke in individuals with heart rhythm disorder atrial fibrillation (AF) more effectively than widely used medication warfarin.

Around 150,000 people in experience a stroke in the UK each year, 15 per cent of which are thought to be a direct result of AF.

Pradaxa was seen to reduce the stroke risk in patients by between 30 per cent and 39 per cent, according to findings presented at the annual scientific sessions of the American College of Cardiology.

Older people who are worried about exercising due to hypertension pressure could use angiotensin receptor blockers to prevent high blood pressure while keeping fit, according to research from the University of Texas.

This would lessen the chance of cardiovascular events such as stroke or heart attack.

Posted by Natalie Edwards


News search form